SRSF2 and acute myeloid leukemia: The most common co-mutations in our patients were those known to frequently co-occur with IDH2 mutations, including mutations in SRSF2, ASXL1, STAG2, and RUNX1; these mutations are associated with older age, secondary AML, and poor outcomes [9, 28–30].